What are our aims?
In the event of an epidemic, and in between ongoing epidemics, this group supports UK research funders to share relevant information, network and communicate to support coherence and collaboration in the funding and the use of research in epidemics preparedness and response.
Response to the novel coronavirus
The UK is ramping up efforts to fund research to accelerate the development of vaccines, diagnostics and cures for the novel coronavirus (2019-nCoV). It is of critical importance that funders come together during this outbreak to ensure coordination on the epidemic response, to understand where support is best placed and that research is shared rapidly and openly.
Some examples of the response from our members:
- Department for Health and Social Care has pledged £20 million to develop a new vaccine for coronavirus and other infectious diseases
- Wellcome is making a pledge of up to £10 million to accelerate research and support global efforts to tackle the ongoing novel coronavirus epidemic
- DHSC, through the NIHR, and UKRI through MRC are jointly launching two rapid-response research calls to tackle 2019-nCoV
- 4 ways Wellcome and DFID are working together to thwart epidemics
- Wellcome has announced a call to strengthen the evidence base to better prevent and control coronavirus (COVID-19) epidemics and to increase research and response capacity.
Who are our members?
- The Academy of Medical Sciences
- The Department of Health & Social Care (DHSC)
- The Department for International Development (DFID)
- UKRI Research Councils, including:
- Arts and Humanities Research Council (AHRC)
- Biotechnology and Biological Sciences Research Council (BBSRC)
- Economic and Social Science Research Council (ESRC)
- Medical Research Council (MRC)
- National Environment Research Council (NERC)
- UKRI International Development Team